PillHydroxyzine Pamoate
Hydroxyzine Pamoate
24 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 25 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
Who makes it24 active · 1 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Bryant Ranch Prepack | repackager | 60 | SUPPLYING |
| Aphena Pharma Solutions - Tennessee, LLC | unknown | 20 | SUPPLYING |
| Proficient Rx LP | unknown | 19 | SUPPLYING |
| Asclemed USA, Inc. | unknown | 14 | SUPPLYING |
| REMEDYREPACK INC. | repackager | 12 | SUPPLYING |
| Preferred Pharmaceuticals Inc. | unknown | 11 | SUPPLYING |
| NuCare Pharmaceuticals, Inc. | unknown | 9 | SUPPLYING |
| Direct_Rx | unknown | 9 | SUPPLYING |
| A-S Medication Solutions | unknown | 8 | SUPPLYING |
| PD-Rx Pharmaceuticals, Inc. | unknown | 5 | SUPPLYING |
| Teva Pharmaceuticals USA, Inc. | unknown | 5 | SUPPLYING |
| Northwind Health Company, LLC | unknown | 5 | SUPPLYING |
| Unit Dose Solutions, Inc. | unknown | 4 | SUPPLYING |
| Sandoz Inc | unknown | 4 | SUPPLYING |
| Amneal Pharmaceuticals of New York LLC | unknown | 4 | SUPPLYING |
+ 10 more labelers
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Apr 13, 2022RECALLRecall (Class II): HydrOXYzine Pamoate Capsules, USP, 50 mg, 100-count bottle, Rx only, MFG: Sandoz Pharma, NDC 0185-0615-01
cGMP deviations: Temperature abuse — Recalling firm: Mckesson Medical-Surgical Inc. Corporate Office — USA nationwide.
- Jan 24, 2014RECALLRecall (Class II): Teva Hydroxyzine Pamoate Capsules, USP, 25 mg, 100- count bottle, Rx Only,Distributed by Teva Pharmaceuticals, USA, Sel…
CGMP Deviations: Hydroxyzine Pamoate Capsules, USP, 25 mg were manufactured using an unapproved material: API was incorrectly released for use in manufacturing. — Recalling firm: Teva Pharmaceuticals USA — Nationwide.
- Jan 24, 2014RECALLRecall (Class II): Teva Hydroxyzine Pamoate Capsules, USP, 100 mg, 100- count bottle,Rx only, Distributed by Teva Pharmaceuticals USA, Sel…
CGMP Deviations: Hydroxyzine Pamoate Capsules, USP, 100 mg were manufactured using an unapproved material: API was incorrectly released for use in manufacturing. — Recalling firm: Teva Pharmaceuticals USA — Nationwide.